Teruhiro Utsugi

2.2k total citations · 1 hit paper
85 papers, 1.8k citations indexed

About

Teruhiro Utsugi is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Teruhiro Utsugi has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 33 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Teruhiro Utsugi's work include Cancer therapeutics and mechanisms (17 papers), Lung Cancer Treatments and Mutations (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Teruhiro Utsugi is often cited by papers focused on Cancer therapeutics and mechanisms (17 papers), Lung Cancer Treatments and Mutations (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Teruhiro Utsugi collaborates with scholars based in Japan, United States and Australia. Teruhiro Utsugi's co-authors include Isaiah J. Fidler, Corazon D. Bucana, Alan J. Schroit, Jerome Connor, Yuji Yamada, Takashi Kobunai, Neil Osheroff, Saburo Sone, Akihiko Nii and Takeshi Ogura and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Teruhiro Utsugi

82 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes.

1991 523 citations Teruhiro Utsugi, Isaiah J. Fidler et al. PubMed profile →

Peers

Countries citing papers authored by Teruhiro Utsugi

Since Specialization

Citations

This map shows the geographic impact of Teruhiro Utsugi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teruhiro Utsugi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teruhiro Utsugi more than expected).

Fields of papers citing papers by Teruhiro Utsugi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teruhiro Utsugi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teruhiro Utsugi. The network helps show where Teruhiro Utsugi may publish in the future.

Co-authorship network of co-authors of Teruhiro Utsugi

This figure shows the co-authorship network connecting the top 25 collaborators of Teruhiro Utsugi. A scholar is included among the top collaborators of Teruhiro Utsugi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teruhiro Utsugi. Teruhiro Utsugi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A2402 mice 2020 ·Scientific Reports* ·Yuki Tanaka, Hiroshi Wada, (unknown), (unknown), Keisuke Yamamura, (unknown), Atsushi Shimizu, (unknown), Kazuhisa Minamiguchi, Koichi Ikizawa, Eiji Sasaki, Teruhiro Utsugi	18
2	Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar–specific ASIT 2018 ·Allergology International ·(unknown), Yuki Tanaka, Akira Yamada, Eiji Sasaki, Teruhiro Utsugi	8
3	TPC-144, a novel reversible LSD1 inhibitor, exhibited strong antitumor activity in preclinical models of AML and SCLC 2016 ·European Journal of Cancer ·(unknown), Shunichi Yamashita, (unknown), Yuzo Kodama, Shoutaro Tsuji, T. Ogawa, Atsushi Osada, Kayo Tanaka, (unknown), Kayoko Matsuo, Teruhiro Utsugi, (unknown)	2
4	Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells 2015 ·PLoS ONE ·Rikio Suzuki, Shohei Kikuchi, Takeshi Harada, Naoya Mimura, Jiro Minami, Hiroto Ohguchi, Yasuhiro Yoshida, M. Sagawa, Güllü Görgün, Diana Cirstea, Francesca Cottini, Jana Jakubı́ková, (unknown), Dharminder Chauhan, Paul G. Richardson, Nikhil C. Munshi, Kiyoshi Ando, Teruhiro Utsugi, Teru Hideshima, Kenneth C. Anderson	19
5	Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition 2014 ·Cancer Research ·Naoya Mimura, Teru Hideshima, Toshiyasu Shimomura, Rikio Suzuki, Hiroto Ohguchi, (unknown), Shohei Kikuchi, Yasuhiro Yoshida, Francesca Cottini, Jana Jakubı́ková, Diana Cirstea, Güllü Görgün, Jiro Minami, Yu‐Tzu Tai, Paul G. Richardson, Teruhiro Utsugi, Atsushi Iwama, Kenneth C. Anderson	66
6	New Challenges and Inspired Answers for Anticancer Drug Discovery and Development 2013 ·Japanese Journal of Clinical Oncology ·Teruhiro Utsugi	29
7	Abstract A272: Intermittent treatment with TAS-120, an irreversible FGFR inhibitor, is effective in tumors harboring a FGFR gene abnormality. 2013 ·Molecular Cancer Therapeutics ·Yoko Nakatsuru, (unknown), Hiroshi Sootome, Hidenori Fujita, Akihiro Hashimoto, Yoshihiro Shibata, Masato Chiba, (unknown), (unknown), Hiroshi Hirai, Teruhiro Utsugi	2
8	142 TAS-2913 is a Mutant Selective EGFR Inhibitor for NSCLC: Characterization Against EGFR T790M in Cell and Xenograft Models 2012 ·European Journal of Cancer ·Kazutaka Miyadera, Masanori Kato, (unknown), Ken‐ichi Ito, Yoshimi Aoyagi, Kazuya Fukasawa, (unknown), Kazuya Yonekura, (unknown), Teruhiro Utsugi	3
9	252 TAS-2104, a Highly Potent and Selective Aurora A Inhibitor, Enhanced Antitumor Activity of Taxanes in Vivo 2012 ·European Journal of Cancer ·K. Ishihara, Norio Masuko, Hiroshi Sootome, Takashi Suzuki, Masayasu Okada, Hiroshi Hirai, Teruhiro Utsugi	2
10	Pleural Mesothelioma Instigates Tumor-Associated Fibroblasts To Promote Progression via a Malignant Cytokine Network 2011 ·American Journal Of Pathology ·Qi Li, Wei Wang, Tadaaki Yamada, Kunio Matsumoto, Katsuya Sakai, Yoshimi Bando, Hisanori Uehara, Yasuhiko Nishioka, Saburo Sone, Shotaro Iwakiri, Kazumi Itoi, Teruhiro Utsugi, Kazuo Yasumoto, Seiji Yano	44
11	Establishment and Characterization of 6‐[[2‐(Dimethylamino)ethyl]amino]‐3‐hydroxy‐7H‐indeno[2,1‐c]quinolin‐7‐one dihydrochloride (TAS‐103)‐resistant Cell Lines 2000 ·PubMed Central ·Yoshimi Aoyagi, Takashi Kobunai, Teruhiro Utsugi, Konstanty Wierzba, (unknown)	5
12	In vitro Antitumor Activity of TAS‐103, a Novel Quinoline Derivative That Targets Topoisomerases I and II 1999 ·Japanese Journal of Cancer Research ·Yoshimi Aoyagi, Takashi Kobunai, Teruhiro Utsugi, Tomoko Oh‐hara, Yuji Yamada	33
13	A Dual Topoisomerase Inhibitor, TAS‐103, Induces Apoptosis in Human Cancer Cells 1999 ·Japanese Journal of Cancer Research ·Tomoko Ohyama, Li Yin, Teruhiro Utsugi, Shinji Irie, Yuji Yamada, Takaaki Sato	13
14	Frozen-thawed human blood monocytes respond reproducibly to activation stimuli: Implications for screening of BRMs 1992 ·Biotherapy ·Teruhiro Utsugi, (unknown), Akihiko Nii, Isaiah J. Fidler	4
15	Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages 1991 ·Cancer Immunology Immunotherapy ·Teruhiro Utsugi, Akihiko Nii, Dominic Fan, Charles C. Pak, Yvonne Denkins, Peter van Hoogevest, Isaiah J. Fidler	17
16	Optimization of the Liposomes Encapsulating a New Lipopeptide CGP 31362 for Efficient Activation of Tumoricidal Properties in Monocytes and Macrophages 1991 ·Journal of Immunotherapy ·Akihiko Nii, Teruhiro Utsugi, (unknown), Yvonne Denkins, Charles Y.C. Pak, (unknown), Peter van Hoogevest, Isaiah J. Fidler	12
17	In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362 1991 ·Cancer Immunology Immunotherapy ·Teruhiro Utsugi, Colin P. Dinney, (unknown), Isaiah J. Fidler	14
18	Differential Effects of Recombinant Interferons , beta, and on Induction of Human Lymphokine (IL-2)-Activated Killer Activity 1988 ·JNCI Journal of the National Cancer Institute ·(unknown), Teruhiro Utsugi, Akihiko Nii, Takeshi Ogura	54
19	Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide. 1986 ·PubMed ·(unknown), Teruhiro Utsugi, Saburo Sone	13
20	Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes. 1986 ·The Journal of Immunology ·Teruhiro Utsugi, S Sone	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact